These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15516023)

  • 1. Absorption pattern of trospium chloride along the human gastrointestinal tract assessed using local enteral administration.
    Schröder S; Jetter A; Zaigler M; Weyhenmeyer R; Krumbiegel G; Wächter W; Fuhr U
    Int J Clin Pharmacol Ther; 2004 Oct; 42(10):543-9. PubMed ID: 15516023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of trospium chloride.
    Doroshyenko O; Jetter A; Odenthal KP; Fuhr U
    Clin Pharmacokinet; 2005; 44(7):701-20. PubMed ID: 15966754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and bioequivalence studies of trospium chloride after a single-dose administration in healthy Chinese volunteers.
    Zhang R; Yuan G; Li R; Liu X; Wei C; Wang B; Gao H; Guo R
    Arzneimittelforschung; 2012 May; 62(5):247-51. PubMed ID: 22382787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the population pharmacokinetic characteristics of once-daily trospium chloride 60 mg extended-release capsules in patients with overactive bladder and in healthy subjects.
    Harnett MD; Shipley J; MacLean L; Schwiderski U; Sandage BW
    Clin Drug Investig; 2013 Feb; 33(2):133-41. PubMed ID: 23203138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of once-daily trospium chloride 60 mg extended release and twice-daily trospium chloride 20 mg in healthy adults.
    Silver N; Sandage B; Sabounjian L; Schwiderski U; Shipley J; Harnett M
    J Clin Pharmacol; 2010 Feb; 50(2):143-50. PubMed ID: 19948948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trospium chloride in the management of overactive bladder.
    Rovner ES
    Drugs; 2004; 64(21):2433-46. PubMed ID: 15482001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the P-Glycoprotein Inhibitor Clarithromycin on the Pharmacokinetics of Intravenous and Oral Trospium Chloride: A 4-Way Crossover Drug-Drug Interaction Study in Healthy Subjects.
    Abebe BT; Weiss M; Modess C; Roustom T; Tadken T; Wegner D; Schwantes U; Neumeister C; Schulz HU; Scheuch E; Siegmund W
    J Clin Pharmacol; 2019 Oct; 59(10):1319-1330. PubMed ID: 30973998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic Drug-Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects.
    Abebe BT; Weiss M; Modess C; Tadken T; Wegner D; Meyer MJ; Schwantes U; Neumeister C; Scheuch E; Schulz HU; Tzvetkov M; Siegmund W
    J Clin Pharmacol; 2020 Mar; 60(3):312-323. PubMed ID: 31542894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of trospium chloride after intravesical instillation in patients with neurogenic lower urinary tract dysfunction: A pilot study.
    Walter P; Grosse J; Bihr AM; Kramer G; Schulz HU; Schwantes U; Stöhrer M
    Neurourol Urodyn; 1999; 18(5):447-53. PubMed ID: 10494116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients?
    Menarini M; Del Popolo G; Di Benedetto P; Haselmann J; Bödeker RH; Schwantes U; Madersbacher H;
    Int J Clin Pharmacol Ther; 2006 Dec; 44(12):623-32. PubMed ID: 17190372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trospium chloride once daily for overactive bladder syndrome: results of a multicenter observational study].
    Notz HJ; Hautumm B; Werdier D; Groves R; Odenthal KP
    Urologe A; 2013 Jan; 52(1):65-70. PubMed ID: 23052979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of rivastigmine from different regions of the gastrointestinal tract in humans.
    Lee L; Hossain M; Wang Y; Sedek G
    J Clin Pharmacol; 2004 Jun; 44(6):599-604. PubMed ID: 15145967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability study of drotaverine from capsule and tablet preparations in healthy volunteers.
    Dyderski S; Grześkowiak E; Drobnik L; Szałek E; Balcerkiewicz M; Dubai V
    Arzneimittelforschung; 2004; 54(5):298-302. PubMed ID: 15212193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of drug transporters and drug metabolizing enzymes in the bladder urothelium in man and affinity of the bladder spasmolytic trospium chloride to transporters likely involved in its pharmacokinetics.
    Bexten M; Oswald S; Grube M; Jia J; Graf T; Zimmermann U; Rodewald K; Zolk O; Schwantes U; Siegmund W; Keiser M
    Mol Pharm; 2015 Jan; 12(1):171-8. PubMed ID: 25466967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of trospium-specific absorption models for fasted and fed states in humans.
    Cvijić S; Langguth P
    Biopharm Drug Dispos; 2014 Dec; 35(9):553-8. PubMed ID: 25044357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of oxybutynin in man.
    Douchamps J; Derenne F; Stockis A; Gangji D; Juvent M; Herchuelz A
    Eur J Clin Pharmacol; 1988; 35(5):515-20. PubMed ID: 3234461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.